| Ali Sajjad, MD | |
|
2945 Hazelwood St Ste 200, Maplewood, MN 55109-5841 | |
| (651) 232-7800 | |
| Not Available |
| Full Name | Ali Sajjad |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 39 Years |
| Location | 2945 Hazelwood St Ste 200, Maplewood, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619913621 | NPI | - | NPPES |
| 039522600 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 38906 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Healtheast St John's Hospital | Maplewood, MN | Hospital |
| Healtheast Woodwinds Hospital | Woodbury, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healtheast Medical Research Institute | 3971407636 | 500 |
News Archive
The Texas Heart Institute and 7 Hills Pharma received a $1.9 million, Phase II STTR (R42) grant from the National Heart Lung Blood Institute to advance further their lead product 7HP349, a novel integrin activator, to define the optimal dosing schedule for cord blood transplant along with a focus on development and production of a formulation that meets safety standards for filing an IND application with the FDA.
Adverse events for patients being treated for heart attack and heart failure have declined, according to a new study published in the January 23 issue of the New England Journal of Medicine. However, the analysis funded by the Agency for Healthcare Research and Quality found that there has not been a significant decrease in adverse events for patients being treated for pneumonia and those who are recovering from surgery.
For more than 250,000 Americans, the bite of a deer tick meant the start of a life changing disease. With record warm temperatures and the start of May's National Lyme Disease Awareness Month, Mosquito Squad is on watch and has six tips to help homeowners tick-proof their yards.
A Harvard-led team is the first to demonstrate the ability to use low-power light to trigger stem cells inside the body to regenerate tissue, an advance they reported in Science Translational Medicine.
› Verified 6 days ago
| Entity Name | Fairview Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013994359 PECOS PAC ID: 1951213057 Enrollment ID: O20031105000461 |
News Archive
The Texas Heart Institute and 7 Hills Pharma received a $1.9 million, Phase II STTR (R42) grant from the National Heart Lung Blood Institute to advance further their lead product 7HP349, a novel integrin activator, to define the optimal dosing schedule for cord blood transplant along with a focus on development and production of a formulation that meets safety standards for filing an IND application with the FDA.
Adverse events for patients being treated for heart attack and heart failure have declined, according to a new study published in the January 23 issue of the New England Journal of Medicine. However, the analysis funded by the Agency for Healthcare Research and Quality found that there has not been a significant decrease in adverse events for patients being treated for pneumonia and those who are recovering from surgery.
For more than 250,000 Americans, the bite of a deer tick meant the start of a life changing disease. With record warm temperatures and the start of May's National Lyme Disease Awareness Month, Mosquito Squad is on watch and has six tips to help homeowners tick-proof their yards.
A Harvard-led team is the first to demonstrate the ability to use low-power light to trigger stem cells inside the body to regenerate tissue, an advance they reported in Science Translational Medicine.
› Verified 6 days ago
| Entity Name | Fairview Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346432218 PECOS PAC ID: 7113830142 Enrollment ID: O20031106000516 |
News Archive
The Texas Heart Institute and 7 Hills Pharma received a $1.9 million, Phase II STTR (R42) grant from the National Heart Lung Blood Institute to advance further their lead product 7HP349, a novel integrin activator, to define the optimal dosing schedule for cord blood transplant along with a focus on development and production of a formulation that meets safety standards for filing an IND application with the FDA.
Adverse events for patients being treated for heart attack and heart failure have declined, according to a new study published in the January 23 issue of the New England Journal of Medicine. However, the analysis funded by the Agency for Healthcare Research and Quality found that there has not been a significant decrease in adverse events for patients being treated for pneumonia and those who are recovering from surgery.
For more than 250,000 Americans, the bite of a deer tick meant the start of a life changing disease. With record warm temperatures and the start of May's National Lyme Disease Awareness Month, Mosquito Squad is on watch and has six tips to help homeowners tick-proof their yards.
A Harvard-led team is the first to demonstrate the ability to use low-power light to trigger stem cells inside the body to regenerate tissue, an advance they reported in Science Translational Medicine.
› Verified 6 days ago
| Entity Name | Healtheast Medical Research Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639125503 PECOS PAC ID: 3971407636 Enrollment ID: O20031124000507 |
News Archive
The Texas Heart Institute and 7 Hills Pharma received a $1.9 million, Phase II STTR (R42) grant from the National Heart Lung Blood Institute to advance further their lead product 7HP349, a novel integrin activator, to define the optimal dosing schedule for cord blood transplant along with a focus on development and production of a formulation that meets safety standards for filing an IND application with the FDA.
Adverse events for patients being treated for heart attack and heart failure have declined, according to a new study published in the January 23 issue of the New England Journal of Medicine. However, the analysis funded by the Agency for Healthcare Research and Quality found that there has not been a significant decrease in adverse events for patients being treated for pneumonia and those who are recovering from surgery.
For more than 250,000 Americans, the bite of a deer tick meant the start of a life changing disease. With record warm temperatures and the start of May's National Lyme Disease Awareness Month, Mosquito Squad is on watch and has six tips to help homeowners tick-proof their yards.
A Harvard-led team is the first to demonstrate the ability to use low-power light to trigger stem cells inside the body to regenerate tissue, an advance they reported in Science Translational Medicine.
› Verified 6 days ago
| Entity Name | Fairview Express Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053952606 PECOS PAC ID: 3375645179 Enrollment ID: O20081028000548 |
News Archive
The Texas Heart Institute and 7 Hills Pharma received a $1.9 million, Phase II STTR (R42) grant from the National Heart Lung Blood Institute to advance further their lead product 7HP349, a novel integrin activator, to define the optimal dosing schedule for cord blood transplant along with a focus on development and production of a formulation that meets safety standards for filing an IND application with the FDA.
Adverse events for patients being treated for heart attack and heart failure have declined, according to a new study published in the January 23 issue of the New England Journal of Medicine. However, the analysis funded by the Agency for Healthcare Research and Quality found that there has not been a significant decrease in adverse events for patients being treated for pneumonia and those who are recovering from surgery.
For more than 250,000 Americans, the bite of a deer tick meant the start of a life changing disease. With record warm temperatures and the start of May's National Lyme Disease Awareness Month, Mosquito Squad is on watch and has six tips to help homeowners tick-proof their yards.
A Harvard-led team is the first to demonstrate the ability to use low-power light to trigger stem cells inside the body to regenerate tissue, an advance they reported in Science Translational Medicine.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ali Sajjad, MD 2925 Chicago Ave, Minneapolis, MN 55407-1321 Ph: (612) 262-4813 | Ali Sajjad, MD 2945 Hazelwood St Ste 200, Maplewood, MN 55109-5841 Ph: (651) 232-7800 |
News Archive
The Texas Heart Institute and 7 Hills Pharma received a $1.9 million, Phase II STTR (R42) grant from the National Heart Lung Blood Institute to advance further their lead product 7HP349, a novel integrin activator, to define the optimal dosing schedule for cord blood transplant along with a focus on development and production of a formulation that meets safety standards for filing an IND application with the FDA.
Adverse events for patients being treated for heart attack and heart failure have declined, according to a new study published in the January 23 issue of the New England Journal of Medicine. However, the analysis funded by the Agency for Healthcare Research and Quality found that there has not been a significant decrease in adverse events for patients being treated for pneumonia and those who are recovering from surgery.
For more than 250,000 Americans, the bite of a deer tick meant the start of a life changing disease. With record warm temperatures and the start of May's National Lyme Disease Awareness Month, Mosquito Squad is on watch and has six tips to help homeowners tick-proof their yards.
A Harvard-led team is the first to demonstrate the ability to use low-power light to trigger stem cells inside the body to regenerate tissue, an advance they reported in Science Translational Medicine.
› Verified 6 days ago
Andrzej Petryk, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1580 Beam Ave, Maplewood, MN 55109 Phone: 651-779-7978 Fax: 651-779-7656 | |
Dr. Rahul Koranne, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 1575 Beam Ave, Maplewood, MN 55109 Phone: 651-232-7800 | |
Sherry A Moriarty, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1850 Beam Ave, Maplewood, MN 55109 Phone: 651-779-2500 Fax: 651-770-8834 | |
Endea J Curry, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2165 White Bear Ave N, Maplewood, MN 55109 Phone: 651-523-9800 Fax: 651-523-9801 | |
Ovidiu George Ardeleanu, MD Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 2165 White Bear Ave N, Maplewood, MN 55109 Phone: 651-523-9800 Fax: 651-523-9801 | |
Madison Therese Brickner, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 2945 Hazelwood St Ste 100, Maplewood, MN 55109 Phone: 651-232-7800 | |
Dr. Thomas Martin Hauth, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2945 Hazelwood St, Maplewood, MN 55109 Phone: 651-232-7800 |